Evidence map›Paper›PMID 31098775›Full record

ReviewCurrent diabetes reports2019

Economic Impact of Diabetes in South Asia: the Magnitude of the Problem.

Kavita Singh, K M Venkat Narayan, Karen Eggleston

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current diabetes reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Observational
  7. Article
  8. Stroke and associated comorbidities in Southeast Asian countries.Neuroprotection (Chichester, England) · 2025
    Review
  9. Article
  10. Green Synthesis of Red Fluorescent Graphene Quantum Dots UsingInternational journal of biomaterials · 2025
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Genetic variation inJournal of diabetes and metabolic disorders · 2022
    Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kavita SinghPublic Health Foundation of India, Plot number 47, Sector 44, Gurugram, Haryana, 122002, India. kavita@ccdcindia.org.
K M Venkat NarayanRollins School of Public Health, Emory University, Atlanta, GA, USA.
Karen EgglestonStanford University, Stanford, CA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewTo critically assess and identify gaps in the current literature on the economic impact of diabetes in South Asia. RECENT

findingsThe total annual (direct medical and non-medical and indirect) costs for diabetes care in South Asia range from $483-$2637 per patient, and on an average 5.8% of patients with diabetes suffer catastrophic spending i.e. when households reduce basic expenditure by 40% to cope with healthcare costs. The mean direct costs per patient are positively associated with a country's gross domestic product (GDP) per capita, although there is wide heterogeneity across South Asian countries. With an estimated 84 million people suffering from diabetes in South Asia, diabetes imposes a substantial economic burden on individuals, families, and society. Since the disease burden increasingly occurs in the most productive midlife period, it adversely affects workforce productivity and macroeconomic development. Diabetes-related complications lead to markedly higher treatment costs, causing catastrophic medical spending for many households, thus underscoring the importance of preventing diabetes-related complications.

Indexed as

Diabetes MellitusAsiaCost of IllnessHealth Care CostsHealth ExpendituresHumansCost-of-illness studiesDiabetes mellitusEconomic impactSouth Asia

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.